145 related articles for article (PubMed ID: 36695557)
41. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
[TBL] [Abstract][Full Text] [Related]
42. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
Van Hoovels L; Vander Cruyssen B; Sieghart D; Bonroy C; Nagy E; Pullerits R; Čučnik S; Dahle C; Heijnen I; Bernasconi L; Benkhadra F; Bogaert L; Van Den Bremt S; Van Liedekerke A; Vanheule G; Robbrecht J; Studholme L; Wirth C; Müller R; Kyburz D; Sjöwall C; Kastbom A; Ješe R; Jovancevic B; Kiss E; Jacques P; Aletaha D; Steiner G; Verschueren P; Bossuyt X
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321875
[TBL] [Abstract][Full Text] [Related]
43. Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort.
Murata K; Ito H; Hashimoto M; Murakami K; Watanabe R; Tanaka M; Yamamoto W; Matsuda S
Arthritis Res Ther; 2020 Nov; 22(1):268. PubMed ID: 33183344
[TBL] [Abstract][Full Text] [Related]
44. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.
Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A
Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962
[TBL] [Abstract][Full Text] [Related]
45. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
[TBL] [Abstract][Full Text] [Related]
46. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
Mjaavatten MD; van der Heijde DM; Uhlig T; Haugen AJ; Nygaard H; Bjørneboe O; Kvien TK
J Rheumatol; 2011 Nov; 38(11):2336-41. PubMed ID: 21965645
[TBL] [Abstract][Full Text] [Related]
47. Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis.
Roos Ljungberg K; Börjesson E; Martinsson K; Wetterö J; Kastbom A; Svärd A
Arthritis Res Ther; 2020 Nov; 22(1):274. PubMed ID: 33225988
[TBL] [Abstract][Full Text] [Related]
48. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
[TBL] [Abstract][Full Text] [Related]
49. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
Goules JD; Goules AV; Tzioufas AG
Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
[TBL] [Abstract][Full Text] [Related]
50. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
51. Benefits of anticitrullinated peptides examination in rheumatoid arthritis.
Belakova G; Manka V; Zanova E; Racay P
Niger J Clin Pract; 2018 Oct; 21(10):1380-1383. PubMed ID: 30297575
[TBL] [Abstract][Full Text] [Related]
52. Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood.
Combier A; Frantz C; Wipff J; Bazeli R; Elhai M; Feydy A; Quartier P; Touanga Ngoti G; Thomas M; Deslandre C; Avouac J; Allanore Y
Joint Bone Spine; 2023 Mar; 90(2):105501. PubMed ID: 36574572
[TBL] [Abstract][Full Text] [Related]
53. Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis.
Hughes-Austin JM; Gan RW; Deane KD; Weisman MH; Demoruelle MK; Sokolove J; Robinson WH; Holers VM; Norris JM; Ix JH
Am J Nephrol; 2017; 46(6):481-487. PubMed ID: 29237149
[TBL] [Abstract][Full Text] [Related]
54. Rheumatoid Meningitis: A Case Review.
Parsons AM; Zuniga LA; Hoxworth JM; Lyons M; Aslam F; Goodman BP
Neurologist; 2018 May; 23(3):83-85. PubMed ID: 29722740
[TBL] [Abstract][Full Text] [Related]
55. Increased IgA anti-citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients.
Rahajoe PS; de Smit M; Schuurmans G; Raveling-Eelsing E; Kertia N; Vissink A; Westra J
J Clin Periodontol; 2020 May; 47(5):552-560. PubMed ID: 32141631
[TBL] [Abstract][Full Text] [Related]
56. What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.
Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Lahmar H; Makni S; Sellami S
Clin Rheumatol; 2012 Feb; 31(2):375-9. PubMed ID: 21952975
[TBL] [Abstract][Full Text] [Related]
57. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.
Trier NH; Holm BE; Heiden J; Slot O; Locht H; Jensen B; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
J Immunol Methods; 2018 Mar; 454():6-14. PubMed ID: 29128424
[TBL] [Abstract][Full Text] [Related]
58. Seroprevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Rheumatic Diseases other than Rheumatoid Arthritis.
Saigal R; Bhakal SS; Goyal L; Goel AD
J Assoc Physicians India; 2018 Apr; 66(4):26-8. PubMed ID: 30347947
[TBL] [Abstract][Full Text] [Related]
59. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
[No Abstract] [Full Text] [Related]
60. Extra-articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement.
Chirila RM; Berianu F; Abril A; Butendieck RR
Immun Inflamm Dis; 2021 Dec; 9(4):1613-1617. PubMed ID: 34473908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]